Sang Hoon Lee | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,507 results for “Sang Hoon Lee”

ABL Bio and MSD Collaborate to Evaluate ABL103 with Keytruda in Solid Tumors

ABL Bio Secures $55 Million from Eli Lilly for Grabody Bispecific Antibody Platform Development

ABL Bio Secures Major Platform Deal with GSK, Eyes Future Acquisition

GSK and ABL Bio Partner on £2 Billion Deal to Overcome Blood-Brain Barrier in Neurodegenerative Disease Treatment

Korean Biotech Platforms Drive Record $13.5 Billion in Technology Exports

Gan & Lee Pharmaceuticals Partners with Brazil to Localize Insulin Production in Landmark Agreement

Myongji Hospital Develops AI-Powered Tool to Predict Ovarian Cancer Drug Resistance

Cenyx Biotech's CX213 Receives FDA IND Approval for Phase 1 Trial in Subarachnoid Hemorrhage

Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results

Alvotech Acquires Swiss Packaging Specialist Ivers-Lee to Expand Biosimilar Manufacturing Capacity

Page 1 of 75